Drug Trial Radar · NCT03738215
Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone
Last checked: Nov 20, 2026Latest source record: Oct 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
759
Actual
Start
Nov 9, 2018
Primary completion
Sep 30, 2021
Study completion Sep 30, 2021
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Nov 13, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD who have had an inadequate response to antidepressants alone.
Conditions
- Major Depressive Disorder
Interventions
CariprazineDrug
Cariprazine supplied in capsules
PlaceboDrug
Placebo supplied in capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total Score Change From Baseline to Week 6 in the MADRS (Montgomery-Åsberg Depression Rating Scale)Time frame: Baseline and Week 6
Locations
125 sites in 7 countries. Site status is shown where the registry gives one.
Alea Research /ID# 234789
Phoenix, Arizona
Atria Clinical Research /ID# 237988
Little Rock, Arkansas
Woodland Research Northwest, LLC /ID# 236641
Rogers, Arkansas
California Pharmaceutical Research Institute /ID# 236732
Anaheim, California
Advanced Research Center /ID# 237957
Anaheim, California
Axiom Research /ID# 236268
Colton, California
ATP Clinical Research, Inc /ID# 236619
Costa Mesa, California
ProScience Research Group /ID# 236442
Culver City, California
Collaborative Neuroscience Research - Orange County /ID# 237639
Garden Grove, California
Irvine Clinical Research /ID# 237409
Irvine, California
Omega Clinical Trials LLC /ID# 238168
La Habra, California
Synergy San Diego /ID# 236654
Lemon Grove, California
Anderson Clinical Research /ID# 236627
Redlands, California
Sharp Mesa Vista Hospital /ID# 235797
San Diego, California
Viking Clinical Research /ID# 236614
Temecula, California
Olympian Clinical Research /ID# 237417
Clearwater, Florida
MD Clinical
Hallandale, Florida
Reliable Clinical Research /ID# 234786
Hialeah, Florida
CNS Healthcare - Jacksonville /ID# 238241
Jacksonville, Florida
Space Coast Neuropsychiatric Research Institute /ID# 235765
Palm Bay, Florida
University of South Florida /ID# 234386
Tampa, Florida
Institute for Advanced Medical Research /ID# 236672
Alpharetta, Georgia
iResearch Atlanta, LLC /ID# 237389
Decatur, Georgia
Psych Atlanta /ID# 235835
Marietta, Georgia
Capstone Clinical Research /ID# 236546
Libertyville, Illinois
Pillar Clinical Research /ID# 235702
Lincolnwood, Illinois
NeuroPsychiatric Research Practice & Associate LTD /ID# 234636
Winfield, Illinois
Lake Charles Clinical Trials /ID# 237723
Lake Charles, Louisiana
J. Gary Booker MD APMC /ID# 234514
Shreveport, Louisiana
Pharmasite Research, Inc. /ID# 237395
Baltimore, Maryland
CBH Health LLC /ID# 234536
Gaithersburg, Maryland
Michigan Clinical Research Institute /ID# 234792
Ann Arbor, Michigan
NeuroBehavioral Medicine Group /ID# 236671
Bloomfield Hills, Michigan
Precise Research Centers /ID# 236598
Flowood, Mississippi
Millennium Psychiatric Associates LLC /ID# 235989
St Louis, Missouri
Alivation Research /ID# 236583
Lincoln, Nebraska
Altea Research Institute /ID# 236726
Las Vegas, Nevada
Hassman Research Institute /ID# 237501
Berlin, New Jersey
Integrative Clinical Trials /ID# 236656
Brooklyn, New York
Manhattan Behavioral Medicine PLLC /ID# 236314
New York, New York
Showing 40 of 125 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.